<DOC>
	<DOCNO>NCT02618161</DOCNO>
	<brief_summary>TITLE Timing HDR brachytherapy EBRT intermediate high risk localise Prostate CAncer patient effect Toxicity Quality life - randomised feasibility trial . SHORT TITLE THEPCA trial Protocol Version Number Date Version 2.1 , date 16 DEC 2014 Study Duration Recruitment Duration 18-24 month Study Centre Southend University Hospital NHS Foundation Trust Objectives Assessment acute toxicity : Genitourinary , gastrointestinal sexual dysfunction various time point . Number Participants 50 participant Main Inclusion Criteria - Patient age &gt; 18 year - Histologically diagnosed Prostate cancer , stag T1b-T3bN0M0 - Any Gleason score - Any PSA level - Patient able consent fill questionnaires Exclusion Criteria - Previous TURP/HoLEP Laser Prostatectomy - Any Metastatic Disease - IPSS &gt; 20 - Pubic arch interference - Lithotomy position anaesthesia possible - Rectal fistula - Prior pelvic radiotherapy Statistical Methodology Analysis Percentages adverse event compare use Fisher 's Exact Test . Toxicity score mean compare use two-sample permutation t-tests , PSA relapse-free survival estimate use Kaplan-Meier compare use log-rank test .</brief_summary>
	<brief_title>Timing HDR With EBRT Localised Prostate Cancer , Toxicity Quality Life Assessment</brief_title>
	<detailed_description>The role radiotherapy management prostate cancer significantly change last decade development Brachytherapy , External Beam Radiotherapy ( EBRT ) , Intensity modulate Radiotherapy ( IMRT ) Image guide Radiotherapy ( IGRT ) . One challenge factor Radiotherapy treatment localise prostate cancer acute late Genitourinary Gastrointestinal toxicity . There several study case series publish literature assess toxicity develop EBRT Brachytherapy treatment prostate cancer EBRT Brachytherapy emerge main stay localised prostate cancer treatment recent year . The low risk localise prostate cancer treat low dose brachytherapy prostatectomy , whereas intermediate high risk localise prostate cancer usually treat EBRT alone along HDR brachytherapy . The recent European guideline suggest consensus regard time HDR brachytherapy EBRT . The schedule vary different institution HDR boost give either EBRT . Few centre deliver HDR in-between fraction EBRT . The EBRT dose range 37.5Gy 15 fraction 45Gy 25 fraction give HDR . The total HDR brachytherapy dose deliver fraction , however single dose 15Gy gain acceptance across world due logistical advantage . The Time gap two Radiotherapy mode delivery generally within 21 day . There consensus timing HDR brachytherapy ( BT ) treat along EBRT . The advantage use HDR Brachytherapy EBRT investigator could potentially identify patient suitable brachytherapy early treatment process . It essential know whether significant difference toxicity treatment outcome especially acute urinary toxicity amongst two treatment approach . It do simple 1:1 ratio randomisation possible participant meet inclusion exclusion criterion . Brachytherapy procedure Procedure carry surgical theatre Southend University Hospital . 1 . Patients undergo prostate implantation general spinal anesthetic use Transrectal ultrasound guide transperineal technique . 2 . Imaging accord local practice use ultrasound , CT MR undertaken 3 . The CTVp define prostate capsule extend include extra capsular seminal vesicle disease . A volumetric expansion 3mm constrain rectum posteriorly add . This define PTV . 4 . Catheter reconstruction dwell time definition undertaken provide treatment plan approval treat clinician . 5 . Treatment deliver optimized plan approve 6 . After completion treatment brachytherapy room implant catheter urinary catheter remove ; anesthesia required procedure . 7 . The patient return ward may discharge home later day follow day Dose prescription A dose 15Gy single treatment exposure define 100 % isodose minimum tumour isodose cover PTV . PTV recommendation D90 : ≥15Gy V100 : ≥95 % Organs risk tolerance dos : Rectum D2cc 12Gy Rectum V100 &lt; 15Gy Urethra D10 &lt; 17.5Gy Urethra D30 &lt; 16.5Gy Urethra V150 0cc External Beam Radiation Therapy ( EBRT ) EBRT would give prostate seminal vesicle , use either Intensity Modulated Radiotherapy ( IMRT ) Volumetric Arc radiotherapy ( VMAT ) dose 4600cGy 23 fraction four half week . The Dose Volume Histogram ( DVH ) would accord local radiotherapy protocol . The gap BT EBRT irrespective sequence exceed 3 week . Therefore total Radiotherapy treatment time seven half week Patients receive neo-adjuvant adjuvant anti androgen therapy 6 month 3 year accord risk stratification disease per standard care All statistical significance test 5 % significance level . For IPSS IIEFS scale score , two mean follow-up assessment compare use two-sided permutation t-test use 1000000 random permutation , 95 % confidence limit difference mean calculate use bootstrap use 9999 re-samplings . There also assessment trend score time use repeat measure analysis variance four follow-up score baseline score covariate . For categorical data base adverse event percentage compare use Fisher 's Exact Test . In small study possible carry full combinatorial calculation Fisher 's Exact Test ( whereas main study 10000 random permutation obtain Monte Carlo approach . ) For difference percentage 95 % confidence limit obtain use Newcombe 's Hybrid Score Interval method . For secondary analysis Prostate-specific antigen relapse-free survival use Kaplan-Meier method , test difference survival curve use log-rank test P-value obtain use permutation test 10000 permutation . Cox proportional hazard multiple regression also use assess effect covariates survival , model comparison carry use likelihood ratio test . The analysis perform use computer program R. All randomise participant included analysis .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Patient age &gt; 18 year Histologically diagnose Prostate cancer , stage T1bT3bN0M0 Any Gleason score Any PSA level Patient able consent fill questionnaires Previous TURP/HoLEP Laser Prostatectomy Any Metastatic Disease IPSS &gt; 20 Pubic arch interference Lithotomy position If Anaesthesia possible Rectal fistula Prior pelvic radiotherapy</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>EBRT HDR Brachytherapy</keyword>
</DOC>